Featured Publications
Multimorbidity and Correlates of Comorbid Depression and Generalized Anxiety Disorder in a Nationally Representative US Sample
Jegede O, Stefanovics E, Rhee T, Rosenheck R. Multimorbidity and Correlates of Comorbid Depression and Generalized Anxiety Disorder in a Nationally Representative US Sample. The Journal Of Nervous And Mental Disease 2023, 211: 355-361. PMID: 36807207, DOI: 10.1097/nmd.0000000000001625.Peer-Reviewed Original ResearchConceptsMajor depressive disorderAdditional psychiatric diagnosesRepresentative US sampleComorbid groupPsychiatric disordersPsychiatric diagnosisPoor mental health qualityMental health-related qualityPoorer mental health-related qualityAnxiety disordersHealth-related qualityAdditional psychiatric disordersNationally Representative US SampleMental health qualityLogistic regression analysisSubstance use disordersNational Epidemiologic SurveyMDD-only groupRelated Conditions-IIISingle disorder groupsGeneralized anxiety disorderSingle diagnosis groupsPsychiatric comorbidityComorbid depressionDepressive disorderRates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample
Jegede O, Rhee TG, Stefanovics EA, Zhou B, Rosenheck RA. Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative U.S sample. Psychiatry Research 2022, 315: 114720. PMID: 35834863, DOI: 10.1016/j.psychres.2022.114720.Peer-Reviewed Original ResearchConceptsSubstance use disordersDual diagnosisPsychiatric disordersIndependent correlatesUse disordersDrug use diagnosesService use characteristicsPoor mental HRQOLRelated Conditions Wave IIINational Epidemiologic SurveyRepresentative US sampleMental HRQOLSUD diagnosisUse diagnosesTreatment needsEpidemiologic SurveyWave IIIAdult traumaMedical problemsSuicide attemptsDiagnosisDisordersAdultsFurther studiesSocial support
2021
Treatment of substance use disorders among black and white adults: rates, correlates, and racial discrimination
Bommersbach TJ, Jegede O, Na PJ, Stefanovics EA, Rhee TG, Rosenheck RA. Treatment of substance use disorders among black and white adults: rates, correlates, and racial discrimination. Journal Of Addictive Diseases 2021, 40: 345-356. PMID: 34747323, DOI: 10.1080/10550887.2021.1997038.Peer-Reviewed Original ResearchConceptsTreatment receiptPast-year SUDCriminal justice involvementSUD treatmentWhite individualsWhite adultsMultivariate analysisBlack individualsIndependent differentiating factorsSubstance use disorder treatmentUse disorder treatmentSubstance use disordersNational Epidemiologic SurveyRelated Conditions-IIILow social supportJustice involvementClinical correlatesRacial groupsPsychiatric disordersPsychiatric treatmentUse disordersEpidemiologic SurveyDisorder treatmentBivariate analysisSociodemographic disadvantage
2019
Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection
Gayam V, Jegede O, Tiongson B, Mandal AK, Sidhu J, Garlapati P. Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection. Digestive Diseases 2019, 38: 232-239. PMID: 31494648, DOI: 10.1159/000502514.Peer-Reviewed Original ResearchConceptsHepatitis C virus infectionC virus infectionNon-psychiatric patientsPsychiatric patientsPsychiatric diagnosisAntiviral treatmentVirus infectionTreatment responsePsychiatric disordersComorbid hepatitis C virus (HCV) infectionDirect-acting antiviral treatmentRetrospective cohort observational studyComorbid substance use disorderNeuropsychiatric adverse effectsPrior treatment statusSustained virologic responseCohort observational studyPrimary psychiatric diagnosisComorbid substance abusePrimary care practicesSubstance use disordersHCV patientsVirologic responseHigh burdenObservational study